Affimed NV (NASDAQ:AFMD)
| 6.63 Delayed Data As of Jul 30 |  -0.20 / -2.93%Today’s Change | 3.07 Today|||52-Week Range 11.74 | +13.92% Year-to-Date |
Latest AFMD News | Press Releases
| 3 Biotech Stocks That Could Rocket Higher Jul 24 / MotleyFool.com - Paid Partner Content | 3 Biotech Stocks That Could Double Soon Jul 21 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 6.83 |
| Today’s open | 6.80 |
| Day’s range | 6.64 - 6.97 |
| Volume | 54,174 |
| Average volume (3 months) | 2,606,308 |
| Market cap | $822.0M |
Data as of 5:14pm ET, 07/30/2021
Growth & Valuation
| Earnings growth (last year) | -0.18% |
| Earnings growth (this year) | +51.59% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +35.03% |
| P/E ratio | NM |
| Price/Sales | 15.03 |
| Price/Book | 7.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STROSutro Biopharma Inc | -0.58 | -3.30% |
| ---- | ||
| ARCTArcturus Therapeutic... | +0.26 | +0.84% |
| --Fountain Healthy Agi... | 0.00 | 0.00% |
Data as of 3:59pm ET, 07/30/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $32.3M |
| Annual profit (last year) | -$47.2M |
| Net profit margin | -145.86% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Heidelberg, Baden Wuerttemberg |
Forecasts
